Clinical trial / 2014
Brown rice blunted postprandial glucose, protected endothelial function, and improved weight and lipids in men with metabolic syndrome.
Researchers evaluated the acute and long-term effects of brown rice (BR) versus white rice (WR) in randomized crossover trials involving men with the metabolic syndrome. In Study 1, postprandial glucose and insulin AUC increases were lower after BR than WR (P=0.041 and P=0.045, respectively), and the decrease in FMD observed 60 min after WR (P=0.037 vs. baseline) was protected after BR. In Study 2 (n=27), 8 weeks of BR consumption decreased weight-based parameters (which returned to baseline after WR), reduced insulin resistance, and lowered total cholesterol and LDL-cholesterol levels.
- Study type
- Randomized crossover trial (acute and 8-week interventions)
- Who was studied
- Male volunteers with or without metabolic syndrome (Study 1) and 27 male volunteers with metabolic syndrome (Study 2)
- What was measured
- Glucose/insulin AUC, FMD and NMD, weight-based parameters, insulin resistance, and lipid levels
THE PAPER
Effects of the brown rice diet on visceral obesity and endothelial function: the BRAVO study.
Shimabukuro M, Higa M, Kinjo R, Yamakawa K, Tanaka H, Kozuka C, Yabiku K, Taira S, Sata M, Masuzaki H. Br J Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.